CF
LYRA

Corebridge Financial’s LYRA THERAPEUTICS INC LYRA Stock Holding History

Corebridge Financial’s Portfolio LYRA Stock Details LYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-474
Closed -$2.99K – 1586
2025
Q1 		$2.99K Sell
474
-7
-1% -$65 ﹤0.01% 3007
2024
Q4 		$4.97K Sell
481
-37
-7% -$407 ﹤0.01% 3020
2024
Q3 		$6.65K Sell
518
-3
-0.6% -$44 ﹤0.01% 3030
2024
Q2 		$7.46K Buy
+521
New +$58.9K ﹤0.01% 3041

Other funds holding LYRA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Corebridge Financial's LYRA Position: Q2 2025 in Review

Corebridge Financial sold out of LYRA THERAPEUTICS INC (LYRA) in Q2 2025, closing a stake of 474 shares — an estimated $2.99K sold.

Corebridge Financial first reported a position in LYRA in Q2 2024 and held it in 4 quarters. The position peaked at $7.46K in Q2 2024. 30 funds tracked by Wall St. Rank hold LYRA as of Q2 2025.

  • Corebridge Financial reported no remaining LYRA THERAPEUTICS INC position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 474 LYRA THERAPEUTICS INC shares in Q2 2025, an estimated $2.99K.
  • Corebridge Financial first reported a position in LYRA THERAPEUTICS INC in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's LYRA THERAPEUTICS INC position peaked at $7.46K in Q2 2024.
  • 30 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.